Evaluation of cardiac microvasculature in patients with diffuse myocardial fibrosis

Octavian Istrătoaie1, Ionica Pirici, Anca Maria OfiŢeru

  • 1Department of Anatomy, University of Medicine and Pharmacy of Craiova, Romania; danapirici@yahoo.com.

Insights

Myocardial fibrosis, a key factor in heart failure, is directly caused by local hypoxia stimulating heart fibroblasts. Reduced microvascular density in patients with hypertension, AF, and heart failure confirms this link.

Area of Science:

  • Cardiology
  • Pathology
  • Physiology

Background:

  • Myocardial fibrosis is a common lesion in chronic heart diseases.
  • Progressive fibrosis can lead to heart failure, a severe condition.
  • The link between fibrosis severity and microcirculation is a critical prognostic factor.

Purpose of the Study:

  • To investigate the relationship between myocardial microcirculation and fibrosis.
  • To evaluate microvascular density in patients with specific cardiovascular conditions.

Main Methods:

  • Assessed myocardial microvascular density in patients.
  • Included patients with hypertension, atrial fibrillation (AF), coronary heart disease, and heart failure.

Main Results:

  • A significant decrease in myocardial microvascular density was observed.
  • This reduction was noted in patients with hypertension, AF, coronary heart disease, and heart failure.

Conclusions:

  • Myocardial fibrosis results from local hypoxia stimulating myocardial fibroblasts.
  • Reduced microvascular density is a direct indicator of fibrosis development in these conditions.

Related Concept Videos